A comparison of methods for the measurement of adherence to antihypertensive multidrug therapy and the clinical consequences: a retrospective cohort study using the Korean nationwide claims database
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES: In observational studies, the methods used to measure medication adherence may affect assessments of the clinical outcomes of drug therapy. This study estimated medication adherence to multidrug therapy in patients with hypertension using different measurement methods and compared their impacts on clinical outcomes. METHODS: This was a retrospective cohort study using the Korean National Health Insurance Service–National Sample Cohort database (2006-2015). Adults diagnosed with hypertension who initiated multidrug antihypertensive therapy in the index year 2007 were included. Adherence was defined as over 80% compliance. Adherence to multidrug antihypertensive therapy was measured in 3 ways using the proportion of days covered (PDC) with 2 approaches to the end-date of the study observations: PDC with at least one drug (PDCwith≥1), PDC with a duration weighted mean (PDCwm), and the daily polypharmacy possession ratio (DPPR). The primary clinical outcome was a composite of cardiovascular and cerebrovascular disease-specific hospitalizations or all-cause mortality. RESULTS: In total, 4,226 patients who initiated multidrug therapy for hypertension were identified. The mean adherence according to the predefined measurements varied from 72.7% to 79.8%. Non-adherence was associated with an increased risk of a primary outcome. The hazard ratios (95% confidence intervals, CIs) primary outcomes varied from 1.38 (95% CI, 1.19 to 1.59) to 1.44 (95% CI, 1.25 to 1.67). CONCLUSIONS: Non-adherence to multidrug antihypertensive therapy was significantly associated with an increased risk of a primary clinical outcome. Across the varying estimates based on different methods, medication adherence levels were similar. These findings may provide evidence to support decision-making when assessing medication adherence.
Abstract
OBJECTIVES: In observational studies, the methods used to measure medication adherence may affect assessments of the clinical outcomes of drug therapy. This study estimated medication adherence to multidrug therapy in patients with hypertension using different measurement methods and compared their impacts on clinical outcomes. METHODS: This was a retrospective cohort study using the Korean National Health Insurance Service–National Sample Cohort database (2006-2015). Adults diagnosed with hypertension who initiated multidrug antihypertensive therapy in the index year 2007 were included. Adherence was defined as over 80% compliance. Adherence to multidrug antihypertensive therapy was measured in 3 ways using the proportion of days covered (PDC) with 2 approaches to the end-date of the study observations: PDC with at least one drug (PDCwith≥1), PDC with a duration weighted mean (PDCwm), and the daily polypharmacy possession ratio (DPPR). The primary clinical outcome was a composite of cardiovascular and cerebrovascular disease-specific hospitalizations or all-cause mortality. RESULTS: In total, 4,226 patients who initiated multidrug therapy for hypertension were identified. The mean adherence according to the predefined measurements varied from 72.7% to 79.8%. Non-adherence was associated with an increased risk of a primary outcome. The hazard ratios (95% confidence intervals, CIs) primary outcomes varied from 1.38 (95% CI, 1.19 to 1.59) to 1.44 (95% CI, 1.25 to 1.67). CONCLUSIONS: Non-adherence to multidrug antihypertensive therapy was significantly associated with an increased risk of a primary clinical outcome. Across the varying estimates based on different methods, medication adherence levels were similar. These findings may provide evidence to support decision-making when assessing medication adherence.
참고문헌 (36)
- Osterberg L, "Adherence to medication", N Engl J Med, 353, pp.487~497 (2005)
- van Staa TP, "A study of the effects of exposure misclassification due to the time-window design in pharmacoepidemiologic studies", J Clin Epidemiol, 47, pp.183~189 (1994)
- Steiner JF, "The assessment of refill compliance using pharmacy records : methods, validity, and applications", J Clin Epidemiol, 50, pp.105~116 (1997)
- Blais L, "Accuracy of the days’ supply and the number of refills allowed recorded in Québec prescription claims databases for inhaled corticosteroids", BMJ Open, 4, pp.e005903~ (2014)
- Coronary Drug Project Research Group, "Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project", N Engl J Med, 303, pp.1038~1041 (1980)
- LaRosa JC, "Poor compliance : the hidden risk factor", Curr Atheroscler Rep, 2, pp.1~4 (2000)
- Horwitz RI, "Adherence to treatment and health outcomes", Arch Intern Med, 153, pp.1863~1868 (1993)
- Senst BL, "Practical approach to determining costs and frequency of adverse drug events in a health care network", Am J Health Syst Pharm, 58, pp.1126~1132 (2001)
- McDonnell PJ, "Hospital admissions resulting from preventable adverse drug reactions", Ann Pharmacother, 36, pp.1331~1336 (2002)
- Zhou B, "Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension", Nat Rev Cardiol, 18, pp.785~802 (2021)
- 김현창, "Korea hypertension fact sheet 2020: analysis of nationwide population-based data", Clinical Hypertension, 27(2), pp.66~69 (2021), 대한고혈압학회[DOI]
- Gossec L, "Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases : a systematic literature review", Am J Med Sci, 334, pp.248~254 (2007)
- Burnier M, "Drug adherence in hypertension", Pharmacol Res, 125, pp.142~149 (2017)
- Hill MN, "Adherence and persistence with taking medication to control high blood pressure", J Am Soc Hypertens, 5, pp.56~63 (2011)
- Touyz RM, "Hypertension 2022 update : focusing on the future", Hypertension, 79, pp.1559~1562 (2022)
- Nau DP, "Proportion of days covered (PDC) as a preferred method of measuring medication adherence", pp.1~3 (2012), Pharmacy Quality Alliance
- Pednekar PP, "Methods for measuring multiple medication adherence : a systematic review-report of the ISPOR medication adherence and persistence special interest group", Value Health, 22, pp.139~156 (2019)
- Quisel T, "The association between medication adherence for chronic conditions and digital health activity tracking : retrospective analysis", J Med Internet Res, 21, pp.e11486~ (2019)
- Hedna K, "Adherence to antihypertensive therapy and elevated blood pressure: should we consider the use of multiple medications?", PLoS One, 10, pp.e0137451~ (2015)
- Zongo A, "Measuring adherence to oral antidiabetic multi-drug treatment : comparative validity of prescription claims-based adherence measures against hospitalization", Res Social Adm Pharm, 15, pp.738~743 (2019)
- Bjarnadottir MV, "Sensitivity of the medication possession ratio to modelling decisions in large claims databases", Pharmacoeconomics, 36, pp.369~380 (2018)
- Choo E, "Comparing the sensitivities of measures of adherence to antihypertensive drugs using Korean National Health Insurance Claims Data", Patient Prefer Adherence, 15, pp.1717~1728 (2021)
- Kwon S, "Payment system reform for health care providers in Korea", Health Policy Plan, 18, pp.84~92 (2003)
- Lee J, "Cohort profile : the National Health Insurance Service-National Sample Cohort(NHIS-NSC), South Korea", Int J Epidemiol, 46, pp.e15~ (2017)
- Choudhry NK, "Measuring concurrent adherence to multiple related medications", Am J Manag Care, 15, pp.457~464 (2009)
- Bansilal S, "Assessing the impact of medication adherence on long-term cardiovascular outcomes", J Am Coll Cardiol, 68, pp.789~801 (2016)
- Pittman DG, "Antihypertensive medication adherence and subsequent healthcare utilization and costs", Am J Manag Care, 16, pp.568~576 (2010)
- Slejko JF, "Adherence to statins in primary prevention : yearly adherence changes and outcomes", J Manag Care Pharm, 20, pp.51~57 (2014)
- Quan H, "Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries", Am J Epidemiol, 173, pp.676~682 (2011)
- Seong SC, "Cohort profile : the National Health Insurance Service-National Health Screening Cohort(NHIS-HEALS)in Korea", BMJ Open, 7, pp.e016640~ (2017)
- 김희진, "Validity of the Diagnosis of Acute Myocardial Infarction in Korean National Medical Health Insurance Claims Data: The Korean Heart Study (1)", Korean Circulation Journal, 42(1), pp.10~15 (2012), 대한심장학회
- 원태영, "사망 통계자료의 정확성에 대한 연구", 대한응급의학회지, 18(3), pp.256~262 (2007), 대한응급의학회
- Zongo A, "Measuring adherence to oral antidiabetic multi-drug treatment : comparative validity of prescription claims-based adherence measures against hospitalization", Res Social Adm Pharm, 15, pp.738~743 (2019)
- Kozma CM, "Medication possession ratio : implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis", Patient Prefer Adherence, 7, pp.509~516 (2013)
- Du L, "The impact of medication adherence on clinical outcomes of coronary artery disease : a meta-analysis", Eur J Prev Cardiol, 24, pp.962~970 (2017)
- Arnet I, "Operationalization and validation of a novel method to calculate adherence to polypharmacy with refill data from the Australian pharmaceutical benefits scheme(PBS)database", Clin Epidemiol, 10, pp.1181~1194 (2018)